Imochem-120 contains imidocarb, a diamidine of the carbanalide series of antiprotozoal
compounds, and is indicated for treatment and prophylaxis of babesiosis in cattle, for treatment
of babesiosis and anaplasmosis in sheep, for treatment of babesiosis in horses and dogs and for
treatment of anaplasmosis in cattle.
Imidocarb is a diamidine of the carbanalide series of antiprotozoal compounds.
Administration to animals with known hypersensitivity to the active ingredient.
Administration to animals exposed to cholinesterase-inhibiting drugs or pesticides.
Administration via the intravenous route.
Administration to ewes producing milk for human consumption.
Administration to animals with impaired renal and/or hepatic functions.
For parenteral administration.
Calves and cattle:
Babesiosis
Treatment of babesiosis: 1.0 ml per 100 kg body weight, subcutaneously.
Prevention of babesiosis: 2.5 ml per 100 kg body weight, subcutaneously, one month
before exposure.
Anaplasmosis
Treatment of anaplasmosis: 2.5 ml per 100 kg bodyweight, subcutaneously.
Elimination of the carrier state: 4.0 ml per 100 kg bodyweight, subcutaneously, administered
twice with a 14-day interval.
Horses:
Treatment of Babesia caballi: 2.0 ml per 100 kg body weight, once daily for 2 consecutive
days, intramuscularly.
Treatment of Babesia equi: 3.5 ml per 100 kg body weight, administered 4 times with a
72-hour interval.
Sheep: 1.0 ml per 100 kg body weight, intramuscularly.
Dogs: 0.5 ml per 10 kg body weight, subcutaneously or
intramuscularly. Repeat the dose in 2 weeks, for a total of 2
treatments.
Milk: 21 days (cattle).
Not to be used in sheep producing milk for human consumption.
Most common adverse effects include pain during injections and mild cholinergic signs (salivation,
vomitting, nasal drip). Cholinergic side effects may be alleviated by treatment with atropine
sulphate. Other effects may include panting, diarrhoea, injection site inflammation, lacrimation,
sweating and restlessness.
